Natera, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for NTRA, updated each market day.
NTRA AI Sentiment
AI sees no strong directional signal for Natera, Inc. Common Stock stock over the next 10 market days.
Prediction date: Oct. 12, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Natera, Inc. Common Stock
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Sector
Exchange
Market Cap
$56,330,100,194
Cap Tier
Employees
6,140
Headquarters
AUSTIN, TX
Listed Since
July 2, 2015
Website
NTRA Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NTRA Volatility
Natera, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
